Artificial Intelligence in Cardiovascular Disease Prevention: Is it Ready for Prime Time? Shyon ParsaSulaiman SomaniFatima Rodriguez Review 23 May 2024
From Atherosclerosis to Spontaneous Coronary Artery Dissection: Defining a Clinical and Genetic Risk Spectrum for Myocardial Infarction Alexander E. KatzTrisha GupteSanthi K. Ganesh Review 18 May 2024
Comparative Analysis of Atherogenic Lipoproteins L5 and Lp(a) in Atherosclerotic Cardiovascular Disease Omer AkyolChao-Yuh YangAntonio M. Gotto Review Open access 16 May 2024
Noninvasive Atherosclerotic Phenotyping: The Next Frontier into Understanding the Pathobiology of Coronary Artery Disease Rafal WolnyJolien GeersDamini Dey Review 10 May 2024
Pharmacotherapy for Coronary Artery Disease and Acute Coronary Syndrome in the Aging Population Errol MorasSyed ZaidChayakrit Krittanawong Review 09 May 2024
Roles and Mechanisms of miRNAs in Abdominal Aortic Aneurysm: Signaling Pathways and Clinical Insights Haorui ZhangKe ZhangChenxi Ouyang Review 06 May 2024
The Effects of FABP4 on Cardiovascular Disease in the Aging Population Ellen M. van der Ark-VonkMike V. PuijkSander W. van der Laan Review Open access 03 May 2024 Pages: 163 - 175
Cardiovascular Health and Disease in the Pakistani American Population Murrium I. SadafUsman Ali AkbarSafi U. Khan Review 26 April 2024
Subclinical Atherosclerosis to Guide Treatment in Dyslipidemia and Diabetes Mellitus Reed MszarMiriam E. KatzMichael J. Blaha Review 25 April 2024
Cardiovascular Effects of Stimulators of Soluble Guanylate Cyclase Administration: A Meta-analysis of Randomized Controlled Trials Cosimo Andrea StamerraPaolo Di GiosiaAmirhossein Sahebkar Review 02 April 2024 Pages: 177 - 187
Oral PCSK9 Inhibitors Anandita AgarwalaRamsha AsimChristie M. Ballantyne Review 27 March 2024 Pages: 147 - 152
Gene Editing for the Treatment of Hypercholesterolemia Menno HoekstraMiranda Van Eck Review Open access 18 March 2024 Pages: 139 - 146
The Role of Genetics in Advancing Cardiometabolic Drug Development Roukoz Abou-KaramFangzhou ChengAkl C. Fahed Review 07 March 2024 Pages: 153 - 162
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2023 American Heart Association Scientific Sessions Melody HermelAndrew ChiouSalim S. Virani Review 05 March 2024 Pages: 119 - 131
European Lipid Guidelines and Cardiovascular Risk Estimation: Current Status and Future Challenges Angela PirilloLale TokgözoğluAlberico L. Catapano Review 02 March 2024 Pages: 133 - 137
Implications of Bias in Artificial Intelligence: Considerations for Cardiovascular Imaging Marly van AssenAshley BeecyJudy Gichoya Review 16 February 2024 Pages: 91 - 102
Novel Therapies for Lipoprotein(a): Update in Cardiovascular Risk Estimation and Treatment Anders Berg WulffBørge G. NordestgaardAnne Langsted Review 05 February 2024 Pages: 111 - 118
How Will Our Practice Change After the CLEAR Outcomes Trial? Timothy AbrahamsAdam J. NelsonStephen J. Nicholls Review Open access 31 January 2024 Pages: 83 - 89
Increased Cardiovascular Risk in Young Patients with CKD and the Role of Lipid-Lowering Therapy Vojtech KratkyAnna ValerianovaJan Malik Review 30 January 2024 Pages: 103 - 109
Lipoprotein(a): from Causality to Treatment Florian Kronenberg Review Open access 22 January 2024 Pages: 75 - 82
Correction to: Whether and Why Do We Need a Vaccine Against Atherosclerosis? Can We Expect It Anytime Soon? Stanisław SurmaAmirhossein SahebkarMaciej Banach Author Correction Open access 22 January 2024 Pages: 73 - 73
Psychological Health and Ischemic Heart Disease in Women: A Review of Current Evidence and Clinical Considerations across the Healthspan Allison E. GaffeyErica S. Spatz Review 19 January 2024 Pages: 45 - 58
Targeting the Gut Microbiome to Treat Cardiometabolic Disease Panagiotis TheofilisPanayotis K. VlachakisDimitris Tousoulis Review 05 January 2024 Pages: 25 - 34
Whether and Why Do We Need a Vaccine Against Atherosclerosis? Can We Expect It Anytime Soon? Stanisław SurmaAmirhossein SahebkarMaciej Banach Review Open access 02 January 2024 Pages: 59 - 71
Risk Stratification and Treatment of Obesity for Primary and Secondary Prevention of Cardiovascular Disease John W. OstrominskiTiffany M. Powell-Wiley Review 30 December 2023 Pages: 11 - 23
Body Fat Depletion: the Yin Paradigm for Treating Type 2 Diabetes Jingjing ZhuJohn P. H. Wilding Review Open access 27 December 2023 Pages: 1 - 10
Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments John J. P. KasteleinAndrew HsiehMichael H. Davidson Review Open access 22 December 2023 Pages: 35 - 44
How to Handle Elevated Triglycerides: Life after PROMINENT Angela PirilloAlberico L. Catapano Review 20 December 2023 Pages: 921 - 929
Eliminating Health Disparities in Atrial Fibrillation, Heart Failure, and Dyslipidemia: A Path Toward Achieving Pharmacoequity Krunal AminGarrett BethelCaroline E. Sloan Review 18 December 2023 Pages: 1113 - 1127
Inhibition of Angiopoietin-Like Protein 3 or 3/8 Complex and ApoC-III in Severe Hypertriglyceridemia Miriam LaroucheEtienne KhouryDaniel Gaudet Review 14 December 2023 Pages: 1101 - 1111
Machine Learning in Invasive and Noninvasive Coronary Angiography Ozan UnluAkl C. Fahed Review 14 December 2023 Pages: 1025 - 1033
Should Familial Hypercholesterolaemia Be Included in the UK Newborn Whole Genome Sequencing Programme? Steve E HumphriesUma RamaswamiNeil Hopper Review 07 December 2023 Pages: 1083 - 1091
Sex Differences in Cardiac Transplantation Alice ChungHeidi HartmanErsilia M. DeFilippis Review 07 December 2023 Pages: 995 - 1001
HDL as a Treatment Target: Should We Abandon This Idea? Floran BegueMarie Laurine ApalamaOlivier Meilhac Review 05 December 2023 Pages: 1093 - 1099
Polysocial Risk Scores: Implications for Cardiovascular Disease Risk Assessment and Management Zulqarnain JavedHarun KundiHassaan Arshad Review 04 December 2023 Pages: 1059 - 1068
Polycystic Ovarian Syndrome: a Risk Factor for Cardiovascular Disease Yulith Roca AlvarezMadison PicoOdayme Quesada Review 04 December 2023 Pages: 1003 - 1011
Heart Failure Treatment in 2023: Is There a Place for Lipid Lowering Therapy? Hana PoloczkováJan Krejčí Review 04 December 2023 Pages: 957 - 964
Emerging Preventive Strategies in Chronic Kidney Disease: Recent Evidence and Gaps in Knowledge Nishigandha PradhanMirela Dobre Review 01 December 2023 Pages: 1047 - 1058
Natural Sirtuin1 Activators and Atherosclerosis: an Overview Karolina ŁanoszkaNimasha Vlčková Review Open access 01 December 2023 Pages: 979 - 994
Caregiver Influences on Eating Behaviors in Children: An Opportunity for Preventing Obesity Lorraine M. SchratzOlivia LarkinChristine Martin Review 30 November 2023 Pages: 1035 - 1045
Lipid Lowering Drugs in Acute Coronary Syndromes (ACS) Natalie ArnoldWolfgang Koenig Review Open access 28 November 2023 Pages: 939 - 946
Machine Learning in Cardiovascular Risk Prediction and Precision Preventive Approaches Nitesh GautamJoshua MuellerSubhi J. Al’Aref Review 27 November 2023 Pages: 1069 - 1081
Gene Regulatory Networks in Coronary Artery Disease Jenny ChengMichael ChengXia Yang Review 27 November 2023 Pages: 1013 - 1023
Rap1 in the Context of PCSK9, Atherosclerosis, and Diabetes Heena AgarwalBrea TinsleyLale Ozcan Review 18 November 2023 Pages: 931 - 937
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2023 European Society of Cardiology Congress Kartik GuptaColin HinkampSalim S. Virani Review 17 November 2023 Pages: 965 - 978
Coronary and Extra-coronary Subclinical Atherosclerosis to Guide Lipid-Lowering Therapy Jelani K. GrantCarl E. Orringer Review 16 November 2023 Pages: 911 - 920
Stratification in Heterozygous Familial Hypercholesterolemia: Imaging, Biomarkers, and Genetic Testing Pablo CorralCarlos A. Aguilar SalinasLaura Schreier ReviewPaper 03 November 2023 Pages: 899 - 909
The Role of Lipid-Lowering Therapy in Post-Stroke Patients: Update and Recommendations E. AvenattiJ. A. Carrasco-AvilaK. Nasir ReviewPaper 26 October 2023 Pages: 889 - 898